← Patent-cliff monitor small molecule CALDOLOR IBUPROFEN
Loss of exclusivity March 2032 latest FDA-listed patent expiry
Company Cumberland → See this company's full patent-cliff portfolio Drug detail Brand name CALDOLOR Active ingredient IBUPROFEN Strength 800MG/8ML (100MG/ML) Dosage form SOLUTION Route INTRAVENOUS Modality Small molecule FDA approval June 2009 Marketing status RX
Listed patents Patent Expires Type 11806400 March 2032 use U-3746 9012508 September 2030 use U-981 9649284 September 2029 use U-2018 8871810 September 2029 use U-981 9295639 September 2029 use U-1756 9114068 September 2029 use U-1735 9138404 September 2029 use U-1756 8735452 September 2029 use U-981
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.